PREHYPO

PreHypo is an innovative solution for CGM manufacturers looking to improve their devices with AI-driven prediction. By combining advanced machine learning with CGM data and biomarkers such as heart rate, we can revolutionize the diabetes management market and give manufacturers a competitive advantage. PreHypo is patented and clinically validated through extensive studies and millions of data points, proving its accuracy and effectiveness... We have proven the power of our technology which has been tested in both clinical setting and during daily living. We are currently setting up new clinical trials to test and further validate our technology.